|
1
|
Daly JM, Fry WA, Little AG, et al:
Esophageal cancer: results of an American College of Surgeons
Patient Care Evaluation Study. J Am Coll Surg. 190:562–573. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Plate K: From angiogenesis to
lymphangiogenesis. Nat Med. 7:151–152. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dumont DJ, Jussila L, Taipale J, et al:
Cardiovascular failure in mouse embryos deficient in VEGF
receptor-3. Science. 282:946–949. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Joukov V, Pajusola K, Kaipainen A, et al:
A novel vascular endothelial growth factor, VEGF-C, is a ligand for
the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Embo J. 15:290–298. 1996.
|
|
5
|
Jeltsch M, Kaipainen A, Joukov V, et al:
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.
Science. 276:1423–1425. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su JL, Yang PC, Shih JY, et al: The
VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells.
Cancer Cell. 9:209–223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su JL, Yen CJ, Chen PS, et al: The role of
the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer.
96:541–545. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Su JL, Chen PS, Chien MH, et al: Further
evidence for expression and function of the VEGF-C/VEGFR-3 axis in
cancer cells. Cancer Cell. 13:557–560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitadai Y, Amioka T, Haruma K, et al:
Clinicopathological significance of vascular endothelial growth
factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J
Cancer. 93:662–666. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arigami T, Natsugoe S, Uenosono Y, et al:
Lymphatic invasion using D2–40 monoclonal antibody and its
relationship to lymph node micrometastasis in pN0 gastric cancer.
Br J Cancer. 93:688–693. 2005.
|
|
11
|
Han FH, Li HM, Zheng DH, He YL and Zhan
WH: The effect of the expression of vascular endothelial growth
factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in
patients with gastric carcinoma. Eur J Surg Oncol. 36:1172–1179
|
|
12
|
Kodama M, Kitadai Y, Tanaka M, et al:
Vascular endothelial growth factor C stimulates progression of
human gastric cancer via both autocrine and paracrine mechanisms.
Clin Cancer Res. 14:7205–7214. 2008. View Article : Google Scholar
|
|
13
|
Witte D, Thomas A, Ali N, Carlson N and
Younes M: Expression of the vascular endothelial growth factor
receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal
adenocarcinoma. Anticancer Res. 22:1463–1466. 2002.PubMed/NCBI
|
|
14
|
Arinaga M, Noguchi T, Takeno S, Chujo M,
Miura T and Uchida Y: Clinical significance of vascular endothelial
growth factor C and vascular endothelial growth factor receptor 3
in patients with nonsmall cell lung carcinoma. Cancer. 97:457–464.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Botting SK, Fouad H, Elwell K, et al:
Prognostic significance of peritumoral lymphatic vessel density and
vascular endothelial growth factor receptor 3 in invasive squamous
cell cervical cancer. Transl Oncol. 3:170–175. 2010. View Article : Google Scholar
|
|
16
|
Van Trappen PO, Steele D, Lowe DG, et al:
Expression of vascular endothelial growth factor (VEGF)-C and
VEGF-D, and their receptor VEGFR-3, during different stages of
cervical carcinogenesis. J Pathol. 201:544–554. 2003.
|
|
17
|
Li R, Younes M, Wheeler TM, et al:
Expression of vascular endothelial growth factor receptor-3
(VEGFR-3) in human prostate. Prostate. 58:193–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jennbacken K, Vallbo C, Wang W and Damber
JE: Expression of vascular endothelial growth factor C (VEGF-C) and
VEGF receptor-3 in human prostate cancer is associated with
regional lymph node metastasis. Prostate. 65:110–116. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours. 7th Edition.
International Union Against Cancer; 2009
|
|
20
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis - correlation in invasive
breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang P, Hong JW, Ubukata H, et al:
Increased density and diameter of lymphatic microvessels correlate
with lymph node metastasis in early stage invasive colorectal
carcinoma. Virchows Arch. 448:570–575. 2006. View Article : Google Scholar
|
|
22
|
Tomita N, Matsumoto T, Hayashi T, et al:
Lymphatic invasion according to D2–40 immunostaining is a strong
predictor of nodal metastasis in superficial squamous cell
carcinoma of the esophagus: algorithm for risk of nodal metastasis
based on lymphatic invasion. Pathol Int. 58:282–287. 2008.
|
|
23
|
Liu B, Ma J, Wang X, et al:
Lymphangiogenesis and its relationship with lymphatic metastasis
and prognosis in malignant melanoma. Anat Rec (Hoboken).
291:1227–1235. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saad RS, Lindner JL, Liu Y and Silverman
JF: Lymphatic vessel density as prognostic marker in esophageal
adenocarcinoma. Am J Clin Pathol. 131:92–98. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou M, He L, Zu X, Zhang H, Zeng H and Qi
L: Lymphatic vessel density as a predictor of lymph node metastasis
and its relationship with prognosis in urothelial carcinoma of the
bladder. BJU Int. 107:1930–1935. 2011. View Article : Google Scholar
|
|
26
|
Skobe M, Hawighorst T, Jackson DG, et al:
Induction of tumor lymphangiogenesis by VEGF-C promotes breast
cancer metastasis. Nat Med. 7:192–198. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Podgrabinska S, Braun P, Velasco P, Kloos
B, Pepper MS and Skobe M: Molecular characterization of lymphatic
endothelial cells. Proc Natl Acad Sci USA. 99:16069–16074. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wissmann C and Detmar M: Pathways
targeting tumor lymphangiogenesis. Clin Cancer Res. 12:6865–6868.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hirakawa S: From tumor lymphangiogenesis
to lymphvascular niche. Cancer Sci. 100:983–989. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ferrara N and Davis-Smyth T: The biology
of vascular endothelial growth factor. Endocr Rev. 18:4–25. 1997.
View Article : Google Scholar
|
|
31
|
Ferrara N: Vascular endothelial growth
factor: basic science and clinical progress. Endocr Rev.
25:581–611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ordonez NG: D2-40 and podoplanin are
highly specific and sensitive immunohistochemical markers of
epithelioid malignant mesothelioma. Hum Pathol. 36:372–380. 2005.
View Article : Google Scholar
|
|
33
|
Franchi A, Gallo O, Massi D, Baroni G and
Santucci M: Tumor lymphangiogenesis in head and neck squamous cell
carcinoma: a morphometric study with clinical correlations. Cancer.
101:973–978. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yonemura Y, Endou Y, Sasaki T, et al:
Surgical treatment for peritoneal carcinomatosis from gastric
cancer. Eur J Surg Oncol. 36:1131–1138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Burton JB, Priceman SJ, Sung JL, et al:
Suppression of prostate cancer nodal and systemic metastasis by
blockade of the lymphangiogenic axis. Cancer Res. 68:7828–7837.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mumprecht V, Honer M, Vigl B, et al: In
vivo imaging of inflammation- and tumor-induced lymph node
lymphangiogenesis by immuno-positron emission tomography. Cancer
Res. 70:8842–8851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zehnder-Fjällman AH, Marty C, Halin C, et
al: Evaluation of anti-VEGFR-3 specific scFv antibodies as
potential therapeutic and diagnostic tools for tumor
lymph-angiogenesis. Oncol Rep. 18:933–941. 2007.PubMed/NCBI
|
